Canada News

Cloudbreak Pharma details patient survey on pinguecula

Approximately 10% of respondents self-identified as currently having pinguecula and were under the care of an eye doctor for the condition. This prevalence is consistent with published epidemiological data for moderate to severe pinguecula. For all stages of the disease, published sources indicate that incidence rises progressively with age, reaching approximately 50% of all older adults. Among this patient population, more than 3 out of 4 respondents rated pinguecula moderately or greatly bothersome. The primary drivers of discomfort reported were general ocular irritation, itchiness, and

redness (hyperemia). Patients also identified key environmental triggers that worsened their symptoms. Leading factors included common everyday occurrences such as allergies, dry or hot weather conditions, excess light exposure, smoking, and wind. When asked about interest in a prescription pharmaceutical treatment option, given that no such FDA-approved therapy currently exists, patients rated their interest a 3.4 on the same 0-to-4 scale, reflecting moderate-to-great interest.

Cloudbreak Pharma, pinguecula, patient survey, unmet need, quality of life, ocular irritation, itching, redness, hyperemia, treatment interest, FDA-approved therapy

4 Comments

  1. So basically everybody’s eyes are irritated and they want a prescription for it, cool. I didn’t even know this was a thing until now. Also why is smoking on the list, like shocking.

  2. Not gonna lie, I thought pinguecula was from staring at screens too long? Like my grandma said it was just “digital eye strain” and now it’s allergies and hot weather. They say no FDA-approved therapy exists but they’re already gauging interest—so does that mean they’re just selling something soon or what? 3.4 out of 4 sounds like they already know the outcome.

  3. Allergies, dry weather, wind, excess light, smoking… so basically live outside and you get itchy red eyes, got it. I wonder if they’re mixing it up with conjunctivitis or something because “redness” could be a lot of things. And “hyperemia” sounds like a fancy word for inflammation so they’re basically saying people are uncomfortable. Hope they actually find something that works, but I’m skeptical when it says FDA-approved therapy doesn’t exist yet and they’re already promoting a treatment option.

Leave a Reply

Your email address will not be published. Required fields are marked *

Are you human? Please solve:Captcha


Secret Link

Warning: foreach() argument must be of type array|object, null given in /home/misryoum/public_html/wp-content/plugins/wp-defender/src/component/class-network-cron-manager.php on line 216